WeVote
Log In

Bill

JA

Bill

A 3546

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

2024-2025 Regular Session Introduced by John Azzariti and 6 co-sponsors

Requires New Jersey insurers and state health plan to fully cover ovarian cancer screening expenses, eliminating patient cost-sharing for preventive screening services.

Reported and Referred to Assembly Financial Institutions and Insurance Committee
#disease #healthinsur #pubempbene #women
0
WeVote Research Nonpartisan
Bill Summary · A 3546

Legislative bill overview

Bill A 3546 mandates that both private insurers and New Jersey's State Health Benefits Plan (SHBP) cover the full cost of ovarian cancer screening procedures without cost-sharing barriers. The bill ensures residents have access to preventive screening regardless of insurance type.

Why is this important

Ovarian cancer is often diagnosed at advanced stages due to lack of accessible early detection methods, making prevention-focused coverage potentially life-saving. Removing financial barriers to screening could increase early detection rates and improve treatment outcomes, though it also increases insurance costs that may be passed to consumers or employers.

Potential points of contention

  • Medical evidence debate: Medical organizations lack consensus on routine ovarian cancer screening effectiveness for asymptomatic women, with some arguing screening harms outweigh benefits through false positives
  • Insurance cost implications: Mandatory coverage expands insurance expenses, potentially raising premiums for all enrollees or reducing coverage in other areas
  • Screening criteria ambiguity: The bill doesn't specify which screening methods qualify (ultrasound, CA-125 blood tests, etc.) or define eligibility criteria, leaving implementation details unclear and potentially allowing unlimited coverage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.